LifeMD, Inc. (LFMD)
Market Cap | 288.30M |
Revenue (ttm) | 245.56M |
Net Income (ttm) | -9.03M |
Shares Out | 47.42M |
EPS (ttm) | -0.21 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,254,768 |
Open | 5.99 |
Previous Close | 6.01 |
Day's Range | 5.99 - 6.25 |
52-Week Range | 3.99 - 15.84 |
Beta | 1.57 |
Analysts | Buy |
Price Target | 12.50 (+105.59%) |
Earnings Date | Nov 6, 2025 |
About LFMD
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications,... [Read more]
Financial Performance
In 2024, LifeMD's revenue was $212.45 million, an increase of 39.27% compared to the previous year's $152.55 million. Losses were -$21.99 million, -7.23% less than in 2023.
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for LFMD stock is "Buy." The 12-month stock price target is $12.5, which is an increase of 105.59% from the latest price.
News

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against LifeMD, Inc. (LFMD)
NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of N...

Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
SAN FRANCISCO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executi...

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options If you suff...

Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements – Hagens Berman
SAN FRANCISCO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executi...

Shareholders who lost money in shares of LifeMD, Inc. (NASDAQ: LFMD) Should Contact Wolf Haldenstein Immediately
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP is notifying investors about a federal securities class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) (“Life...

Berger Montague PC Investigates Securities Claims Against LifeMD, Inc. (NASDAQ: LFMD)
PHILADELPHIA , Sept. 4, 2025 /PRNewswire/ -- Berger Montague PC , national plaintiffs' law firm, announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on beh...

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options

LifeMD to Participate in Three Investor Conferences During September
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following inv...

LifeMD: The Dip Could Deepen, Valuation More Attractive
LifeMD saw year-over-year revenue growth for its second quarter slow markedly from the comparable figure in the first quarter. Gross profit margins dipped 200 basis points, versus its year-ago period,...

LFMD Investors Have Opportunity to Join LifeMD, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $LFMD--LFMD Investors Have Opportunity to Join LifeMD, Inc. Fraud Investigation with the Schall Law Firm.

LifeMD, Inc. Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses

LifeMD, Inc. (LFMD) Q2 2025 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman & CEO Marc Benathen - Chief Financial Officer Conference Call Pa...

LifeMD Reports Second Quarter 2025 Results
Total revenue increased 23% year-over-year to $62.2 million; adjusted EBITDA rose 223% to $7.1 million Telehealth revenue increased 30% to $48.6 million; telehealth adjusted EBITDA rose 560% to $3.4 m...

Medifast Announces Second Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter...

LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the Canaccord Genuity 45th Annual Gro...

LifeMD Names COO and Promotes Two Executives
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services, today announced the appointment of Shayna Webb Dray as its Chief Operating O...

LifeMD: Inflection Into Profitability Should Drive Stock Upward
LifeMD is a fast-growing, profitable telehealth company with strong partnerships, a robust tech stack and a valuable SaaS asset. The Novo Nordisk/Hims fallout is bullish, not bearish, for LifeMD. Novo...

LifeMD: An Overlooked GLP-1 Beneficiary
LifeMD has evolved through multiple rebrandings, now offering 24/7 virtual primary and urgent care access to patients. The company operates RexMD, a men's telehealth platform, serving around 500,000 c...

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend...

LifeMD to Participate in Two Investor Conferences During June
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following inv...

LifeMD: Growth, Growth, And More Growth
LifeMD is experiencing a major growth inflection, with record Q1 revenue, first-ever GAAP profitability, and strong subscriber and margin gains. Multiple growth drivers - including GLP-1 programs, Med...

Top 2 Health Care Stocks That May Implode In Q2
As of May 23, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter Bundled Offer Includes Wegovy® at $199 and LifeMD's Virt...

LifeMD to Participate in Three Investor Conferences During May
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following inve...

LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - Chief Financial Officer Conference Call Par...